AI assistant
Podravka d.d. — Interim / Quarterly Report 2013
Jul 18, 2013
2084_10-q_2013-07-18_b90499dc-0966-496b-ab41-d7012dcb0f63.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
MANAGEMENT BOARD
Koprivnica, 18th July 2013
PODRAVKA GROUP
$1. - 6.2013.$
QUARTERLY FINANCIAL REPORT
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no. MBS 010006549, PIN 18928523252
Privredna banka Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,6
| Appendix 1 Reporting period: |
1.1.2013 to |
30.6.2013. |
|---|---|---|
| Quarterly financial report of entrepreneur - TFI-POD | ||
| Registration number (MB) 03454088 |
||
| Identification number of subject (MBS) 010006549 |
||
| 18928523252 Personal identification number (OIB) |
||
| Issueer company: PODRAVKA prehrambena industrija d.d., KOPRIVNICA | ||
| Postal code and place 48000 |
KOPRIVNICA | |
| Street and number ANTE STARČEVIĆA 32 | ||
| E-mail address: [email protected] | ||
| Internet adress: www.podravka.com | ||
| KOPRIVNICA Code and name of comune/town 201 |
||
| Code and county name $6\phantom{1}$ |
KOPRIVNIČKO-KRIŽEVAČKA | Number of employees 5.920 |
| Consolidated statement YES |
(at quarter end) NKD/NWC code: 1039 |
|
| Subsidiaries subject to consolidation (according to IFRS): | Headquarters | Registration number: |
| BELUPO d.d. | Koprivnica | 3805140 |
| DANICA d.o.o. | Koprivnica | 0991279 |
| ITAL-ICE d.o.o. | Poreč | 3746011 |
| PODRAVKA POLSKA SP z.o.o. | Kostrzyn, Polska | 5981449907 |
| PODRAVKA LAGRIS a.s. | Dolni Lhota u Luhačovic, Češka | 3042510487 |
| PODRAVKA SARAJEVO d.o.o. | Sarajevo, BiH | 20188537 |
| Book keeping service: | |
|---|---|
| Contact person: Celiščak Draga | |
| (authorised person for representation) | |
| Phone number: 048 651 200 | Fascimile: 048 220 562 |
| E-mail address: [email protected] |
(authorised person for representation)
Disclosure documents:
-
Financial statements (balance sheet, profit and loss account, cash flow statement, statement
-
shareholders' equity and notes to the financial statements)
-
- Interim management Report
-
- Statement of responsible persons for preparation of financial statements
(signed by authorised person for representation)
BALANCE SHEET as at 30.6.2013.
| Obligator: Podravka prehrambena industrija d.d., Koprivnica | |||
|---|---|---|---|
| Item | AOP code |
Last year (net) | Current year (n e t) |
| H | $\overline{\mathbf{2}}$ | 3 | 4 |
| ASSETS | |||
| A) RECEIVABLES FOR SUBSCRIBED BUT NOT PAID-IN CAPITAL | 001 002 |
1.721.143.991 | 1.674.391.511 |
| B) LONG-TERM ASSETS (003+010+020+029+033) I. INTANGIBLE ASSETS (004 to 009) |
003 | 279.641.788 | 275.126.485 |
| 1. Assets development | 004 | 5.839.794 | 8.469.527 |
| 2. Concessions, patents, licences fees, trade and service marks, software and other rights | 005 | 210.946.610 | 202.374.569 |
| 3. Goodwill | 006 | 41.983.000 | 41.983.000 |
| 4. Prepayments for purchase of intangible assets | 007 | 0 | 972.400 |
| 5. Intangible assets in preparation | 008 | 20.872.384 | 21.326.989 |
| 6. Other intangible assets | 009 | $\mathbf 0$ | |
| II. TANGIBLE ASSETS (011 to 019) | 010 | 1.400.738.837 | 1.359.080.225 |
| 1. Land | 011 | 45.995.536 | 45.670.805 |
| 2. Buildings | 012 | 882.052.504 | 850.763.877 |
| 3. Plant and equipment | 013 | 383.931.370 | 367.325.304 |
| 4. Tools, facility inventory and transport assets | 014 | 18.257.354 | 17.362.274 |
| 5. Biological assets | 015 | 0 | 0 |
| 6. Prepayments for tangible assets | 016 | 276.374 | 1.625.807 |
| 7. Tangible assets in progress | 017 | 68.046.263 | 74.161.643 |
| 8. Other tangible assets | 018 | 2.179.436 | 2.170.515 |
| 9. Investments in buildings | 019 | 0 | $\mathbf 0$ |
| III. LONG-TERM FINANCIAL ASSETS (021 to 028) | 020 | 5.343.367 | 4.813.353 |
| 1. Investments (shares) with related parties | 021 | 0 | 0 |
| 2. Loans given to related parties | 022 | $\Omega$ | 0 |
| 3. Participating interest (shares) | 023 | 983.600 | 983,600 |
| 4. Loans to entrepreneurs in whom the entity holds participating interests | 024 | 0 | $\mathbf{0}$ |
| 5. Investments in securities | 025 | 167.438 | 165.346 |
| 6. Loans, deposits and similar assets | 026 | 4.192.329 | 3.664.407 |
| 7. Other long - term financial assets | 027 | 0 | 0 |
| 8. Investments accounted by equity method | 028 | $\Omega$ | $\overline{0}$ |
| IV. RECEIVABLES (030 to 032) | 029 | $\overline{0}$ | $\mathbf{0}$ |
| 1. Receivables from related parties | 030 | $\ddot{o}$ | $\ddot{\text{o}}$ |
| 2. Receivables from based on trade loans | 031 | $\mathbf 0$ | $\theta$ |
| 3. Other receivables | 032 | 0 | $\Omega$ |
| V. DEFERRED TAX ASSETS | 033 | 35.420.000 | 35.371.447 |
| C) SHORT TERM ASSETS (035+043+050+058) | 034 | 1.881.578.696 | 1.827.158.811 |
| I. INVENTORIES (036 to 042) | 035 | 695.533.146 | 676.707.775 |
| 1. Raw-material and supplies | 036 | 225.184.409 | 197.913.151 |
| 2. Work in progress | 037 | 40.020.809 | 32.186.967 |
| 3. Finished goods | 038 | 213.453.413 | 213.567.127 |
| 4. Merchandise | 039 | 152.458.369 | 168.799.267 |
| 5. Prepayments for inventories | 040 | O | $\Omega$ |
| 6. Long - term assets held for sales | 041 | 64.416.146 | 64.241.262 |
| 7. Biological assets | 042 | $\Omega$ | 0 |
| II. RECEIVABLES (044 to 049) | 043 | 1.062.608.440 | 929.288.119 |
| 1. Receivables from related parties | 044 | 0 | 0 |
| 2. Accounts receivable | 045 046 |
1.011.101.739 0 |
883.205.716 0 |
| 3. Receivables from participating parties 4. Receivables from employees and members of related parties |
047 | 2.569.918 | 2.186.817 |
| 5. Receivables from government and other institutions | 048 | 46.107.062 | 26.299.626 |
| 6. Other receivables | 049 | 2.829.721 | 17.595.960 |
| 050 | 5.229.582 | 43.418.804 | |
| III. SHORT TERM FINANCIAL ASSETS (051 to 057) 1. Shares (stocks) in related parties |
051 | 0 | $\mathbf 0$ |
| 2. Loans given to related parties | 052 | 0 | $\mathbf 0$ |
| 3. Participating interests (shares) | 053 | $\mathbf 0$ | |
| 4. Loans to entrepreneurs in whom the entity holds participating interests | 054 | o | 0 |
| 5. Investments in securities | 055 | 4.002.211 | 16.596.891 |
| 6. Loans, deposits, etc. | 056 | 1.227.371 | 26.813.213 |
| 7. Other financial assets | 057 | 0 | 8.700 |
| IV. CASH AT BANK AND IN CASHIER | 058 | 118.207.528 | 177.744.113 |
| D) PREPAID EXPENSES AND ACCRUED REVENUE | 059 | 14.949.622 | 12.681.542 |
| E) TOTAL ASSETS (001+002+034+059) | 060 | 3.617.672.309 | 3.514.231.864 |
| F) OFF-BALANCE RECORDS | 061 | 858.816.749 | 908.777.772 |
| Obligator: Podravka prehrambena industrija d.d., Koprivnica | |||
|---|---|---|---|
| Item | Last year (net) | Current year (net) |
|
| ï | 2 | 3 | 4 |
| LIABILITIES AND CAPITAL | |||
| A) CAPITAL AND RESERVES (063+064+065+071+072+075+078) | 062 | 1.627.791.411 | 1.656.830.536 |
| I. SUBSCRIBED CAPITAL | 063 | 1.626.000.900 | 1.626.000.900 |
| II. CAPITAL RESERVES | 064 | 26.465.000 | 26.465.000 |
| III.RESERVES FROM PROFIT (066+067-068+069+070) | 065 | 105.899.405 | 99.852.633 |
| 1. Reserves prescribed by low | 066 | 18.325.000 | 18.325.000 |
| 2. Reserves for treasury shares | 067 | 21.761.692 | 21.761.692 |
| 3. Treasury stocks and shares (deduction) | 068 | 67.604.502 | 67.604.502 |
| 4. Statutory reserves | 069 | 35.243.962 | 39.293.993 |
| 5. Other reserves | 070 | 98.173.253 | 88.076.450 |
| IV. REVALUATION RESERVES | 071 | $^{\circ}$ | $\mathbf{O}$ |
| V. RETAINED EARNINGS OR ACCUMULATED LOSS (073-074) | 072 | $-148.498.899$ | $-166.651.100$ |
| 1. Retained earnings | 073 | $\Omega$ | |
| 2. Accumulated loss | 074 | 148.498.899 | 166.651.100 |
| VI. PROFIT/LOSS FOR THE CURRENT YEAR (076-077) | 075 | $-14.101.876$ | 38,895.792 |
| 1. Profit for the current year | 076 | 0 | 38.895.792 |
| 2. Loss for the current year | 077 | 14.101.876 | $\overline{0}$ |
| IX. MINORITY INTERESTS | 078 | 32.026.882 | 32.267.311 |
| B) PROVISIONS (080 to 082) | 079 | 46.777.777 | 52,548.427 |
| 1. Provisions for pensions, severance pay, and similar liabilities | 080 | 25.838.060 | 25.754.195 |
| 2. Reserves for tax liabilities | 081 | $\Omega$ | $\mathbf{O}$ |
| 3. Other reserves | 082 | 20.939.717 | 26.794.232 |
| C) LONG - TERM LIABILITIES (084 to 092) | 083 | 733.553.063 | 625.921.388 |
| 1. Liabilities to related parties | 084 | 0 | $\overline{0}$ |
| 2. Liabilities for loans, deposits etc. | 085 | 0 | $\mathbf{0}$ |
| 3. Liabilities to banks and other financial institutions | 086 | 727.255.063 | 619.986.388 |
| 4. Liabilities for received prepayments | 087 | 0 | 0 |
| 5. Accounts payable | 088 | $\mathbf 0$ | $\mathbf 0$ |
| 6. Liabilities arising from debt securities | 089 | $\overline{O}$ | $\mathbf 0$ |
| 7. Liabilities to entrepreneurs in whom the entity holds participating interests | 090 | $\Omega$ | 0 |
| 8. Other long-term liabilities | 091 | 0 | $\mathbf{0}$ |
| 9. Deferred tax liability | 092 | 6,298.000 | 5.935.000 |
| D) SHORT - TERM LIABILITIES (094 to 105) | 093 | 1.106.272.027 | 1.065.465.513 |
| 1. Liabilities to related parties | 094 | $\mathbf 0$ | $\theta$ |
| 2. Liabilities for loans, deposits etc. | 095 | $\mathbf{0}$ | $\Omega$ |
| 3. Liabilities to banks and other financial institutions | 096 | 477.866.741 | 520.795.139 |
| 4. Liabilities for received prepayments | 097 | 3.155.766 | 192.072 |
| 5. Accounts payable | 098 | 546.406.547 | 456.045.805 |
| 6. Liabilities arising from debt securities | 099 | 0 | 1.092.210 |
| 7. Liabilities to entrepreneurs in whom the entity holds participating interests | 100 | $\Omega$ | $\theta$ |
| 8. Liabilities to employees | 101 | 55.823.800 | 61.613.371 |
| 9. Liabilities for taxes, contributions and similar fees | 102 | 9.408.218 | 12.097.885 |
| 10. Liabilities to share - holders | 103 | 681.378 | 681.138 |
| 11. Liabilities for long-term assets held for sale | 104 | $\mathbf 0$ | 0 |
| 12. Other short - term liabilities | 105 | 12.929.577 | 12.947.893 |
| E) DEFFERED SETTLEMENTS OF CHARGES AND INCOME DEFERRED TO FUTURE PERIOD | 106 | 103.278.032 | 113.466.000 |
| F) TOTAL - CAPITAL AND LIABILITIES (062+079+083+093+106) | 107 | 3.617.672.309 | 3.514.231.864 |
| G) OFF-BALANCE RECORDS | 108 | 858.816.749 | 908.777.772 |
| APPENDIX to balance sheet(to be filled in by entrepreneur that prepares consolidated annual financial report) | |||
| CAPITAL AND RESERVES | |||
| 1. Attributed to equity holders of parent company | 109 | 1.595.764.529 | 1.624.563.225 |
| 2. Attributed to minority interest | 110 | 32.026.882 | 32.267.311 |
PROFIT AND LOSS ACCOUNT
for the period 1.1.2013. to 30.6.2013.
| Obligator: Podravka prehrambena industrija d.d., Koprivnica | ||||||
|---|---|---|---|---|---|---|
| Item | AOP | Last Year | Current year | |||
| code | ||||||
| Cumulative | Quarterly | Cumulative | Quarterly | |||
| ч | $\overline{2}$ | $\overline{3}$ | $\overline{4}$ | 5 | $\epsilon$ | |
| . OPERATING REVENUE (112+113) | 111 | 1.774.697.451 | 943.656.236 | 1.728.535.330 | 908.346.872 | |
| 1. Sales revenue | 112 | 1.720.473.001 | 905.281.813 | 1.695.246.259 | 891.092.844 | |
| 2. Other operating revenues II. OPERATING EXPENSES (115+116+120+124+125+126+129+130) |
113 114 |
54.224.450 1.690.632.837 |
38,374.423 896.701.180 |
33.289.071 1.654.587.886 |
17.254.028 843.552.737 |
|
| 1. Changes in value of work in progress and finished products | 115 | 9.749.978 | 29.987.914 | 6.997.727 | 24.309.269 | |
| 2. Material costs (117 to 119) | 116 | 1.094.740.907 | 564.442.767 | 1.063.513.464 | 546.797.834 | |
| a) Raw material and material costs | 117 | 610.999.627 | 301.269.827 | 548.545.367 | 264.671.194 | |
| b) Costs of goods sold | 118 | 233.622.144 | 122.139.393 | 264.235.116 | 134.012.450 | |
| c) Other external costs | 119 | 250.119.136 | 141.033.547 | 250.732.981 | 148.114.190 | |
| 3. Staff costs (121 to 123) | 120 | 369.926.436 | 187.183.249 | 334.915.467 | 171.034.850 | |
| a) Net salaries and wages | 121 | 223.806.314 | 112.922.929 | 202.624.600 | 103.186.488 | |
| b) Cost for taxes and contributions from salaries | 122 123 |
97.429.456 48.690.667 |
49.478.899 24.781.421 |
88.208.434 44.082.433 |
45.207.286 22.641.076 |
|
| c) Contributions on gross salaries 4. Depreciation |
124 | 76.557.960 | 38.234.302 | 75.735.529 | 37.440.718 | |
| 5. Other costs | 125 | 102.646.346 | 61.763.207 | 127.154.240 | 47.357.614 | |
| 6. Impairment (127+128) | 126 | 7.553.501 | 2.522.652 | 8.971.773 | $-3,138,074$ | |
| a) Impairment of long-term assets (financial assets excluded) | 127 | O | $\mathbf{0}$ | $\Omega$ | $\Omega$ | |
| b) Impairment of short - term assets (financial assets excluded) | 128 | 7,553.501 | 2.522.652 | 8,971,773 | $-3.138.074$ | |
| 7. Provisions | 129 | 1,963,777 | 180.192 | 1.654.464 | 965.583 | |
| 8. Other operating costs | 130 | 27.493.932 | 12.386.897 | 35.645.222 | 18.784.943 | |
| III. FINANCIAL INCOME (132 to 136) | 131 | 24.072.979 | 4.835.131 | 31.856.071 | 19.134.291 | |
| 1. Interest income, foreign exchange gains, dividends and similar income from related parties | 132 | $\Omega$ | 0 | 0 | $\Omega$ | |
| 2. Interest income, foreign exchange gains, dividends and similar income from non - related parties 3. Share in income from affiliated entrepreneurs and participating interests |
133 134 |
24.010.251 | 4.784,233 | 27.436.512 $\Omega$ |
16,950.510 $\Omega$ |
|
| 4. Unrealized gains (income) from financial assets | 135 | 62.728 | 50.898 | 4.419.559 | 2.183.781 | |
| 5. Other financial income | 136 | 0 | $\Omega$ | |||
| IV. FINANCIAL EXPENSES (138 do 141) | 137 | 59.849.620 | 25.826.780 | 53.358.816 | 27.283.302 | |
| 1. Interest expenses, foreign exchange losses, dividends and similar expenses from related parties | 138 | 0 | 0 | $\Omega$ | ||
| 2. Interest expenses, foreign exchange losses, dividends and similar expenses from non - related | 139 | 59.626.669 | 25.815.334 | 53.358.816 | 27,283,302 | |
| 3. Unrealized losses (expenses) on financial assets | 140 | 222.951 | 11.446 | 0 | 0 | |
| 4. Other financial expenses | 141 | 0 | 0 | $\Omega$ | $\circ$ | |
| INCOME FROM INVESTMENT - SHARE IN PROFIT OF ASSOCIATED ENTREPRENEURS IV. |
142 | 0 | $\Omega$ | $\Omega$ | $\overline{0}$ | |
| VI. LOSS FROM INVESTMENT - SHARE IN LOSS OF ASSOCIATED ENTREPRENEURS | 143 144 |
$\Omega$ | $\Omega$ | $\Omega$ | $\overline{0}$ 0 |
|
| VII. EXTRAORDINARY - OTHER INCOME VIII. EXTRAORDINARY - OTHER EXPENSES |
145 | $\Omega$ | ||||
| IX. TOTAL INCOME (111+131+142 + 144) | 146 | 1,798.770.430 | 948.491.367 | 1.760.391.401 | 927.481.163 | |
| X. TOTAL EXPENSES (114+137+143 + 145) | 147 | 1,750.482,457 | 922.527.960 | 1.707.946.702 | 870.836.039 | |
| XI. PROFIT OR LOSS BEFORE TAXATION (146-147) | 148 | 48.287.973 | 25.963.407 | 52.444.699 | 56.645.124 | |
| 1. Profit before taxation (146-147) | 149 | 48.287.973 | 25.963.407 | 52.444.699 | 56.645.124 | |
| 2. Loss before taxation (147-146) | 150 | 0 | $\Omega$ | $\overline{0}$ | ||
| XII. PROFIT TAX | 151 | 10.791.077 | 6.495,500 | 13.078.581 | 7.988.353 | |
| XIII. PROFIT OR LOSS FOR THE PERIOD (148-151) | 152 | 37.496.896 | 19.467.907 | 39.366.118 | 48.656.771 | |
| 1. Profit for the period (149-151) | 153 154 |
37.496.896 0 |
19.467.907 01 |
39.366.118 $\Omega$ |
48.656.771 $\boldsymbol{0}$ |
|
| 2. Loss for the period (151-148) APPENDIX to P&L account (to be filled in by entrepreneur that prepares consolidated financial report) |
||||||
| XIV. PROFIT OR LOSS FOR THE PERIOD | ||||||
| 1. Attributed to equity holders of parent company | 155 | 39.104.899 | 20.364.910 | 38.895,792 | 47.888.763 | |
| 2. Attributed to minority interest | 156 | $-1.608.003$ | $-897.003$ | 470.326 | 768.008 | |
| STATEMENT OF OTHER COMPREHENSIVE INCOME (IFRS) | ||||||
| I. PROFIT OR LOSS FOR THE PERIOD (= 152) | 157 | 37.496.896 | 19.467.907 | 39.366.118 | 48.656.771 | |
| II. OTHER COMPREHENSIVE INCOME / LOSS BEFORE TAX (159 do 165) | 158 | 6.036.259 | $-3.796.852$ | $-10,327,890$ | $-8.423.969$ | |
| 1. Exchange differences on translation of foreign operations | 159 | 6.036.259 | $-3.796.852$ | $-10.327.890$ | $-8.423.969$ | |
| 2. Movements in revaluation reserves of long - term tangible and intangible assets | 160 | |||||
| 3. Profit or loss from reevaluation of financial assets available for sale 4. Gains or losses on efficient cash flow hedging |
161 162 |
|||||
| 5. Gains or losses on efficient hedge of a net investment in foreign countries | 163 | |||||
| 6. Share in other comprehensive income / loss of associated companies | 164 | |||||
| 7. Actuarial gains / losses on defined benefit plans | 165 | |||||
| III. TAX ON OTHER COMPREHENSIVE INCOME FOR THE PERIOD | 166 | |||||
| IV. NET OTHER COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (158-166) | 167 | 6.036.259 | $-3.796.852$ | $-10.327.890$ | $-8.423.969$ | |
| V. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (157+167) | 168 | 43,533.155 | 15.671.055 | 29 038 228 | 40,232.802 | |
| APPENDIX to Statement of other comprenhensive income (to be filled in by entrepreneur that prepares consolidated financial report) | ||||||
| VI. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD | ||||||
| 1. Attributed to equity holders of parent company | 169 170 |
45.182.314 $-1.649.159$ |
16.558.432 $-887.377$ |
28,797.799 240,429 |
39.786.751 446.051 |
|
| 2. Attributed to minority interest |
STATEMENT OF CASH FLOWS - INDIRECT METHOD
for the period 1.1.2013. to 30.6.2013.
| Obligator: Podravka prehrambena industrija d.d., Koprivnica | |||||
|---|---|---|---|---|---|
| Item | AOP code |
Last year | Current year | ||
| $\overline{2}$ | $\mathbf{3}$ | $\overline{\mathcal{A}}$ | |||
| CASH FLOW FROM OPERATING ACTIVITIES | |||||
| 1. Profit before tax | 001 | 48.287.973 | 52.444.699 | ||
| 2. Depreciation | 002 | 76.557.960 | 75.735.529 | ||
| 3. Increase in short term liabilities | 003 | 54.653.203 | |||
| 4. Decrease in short term receivables | 004 | 0 | 110.601.599 | ||
| 5. Decrease in inventories | 005 | 13.098.200 | 24.050.457 | ||
| 6. Other increase in cash flow | 006 | 3.074.000 | 5.601.000 | ||
| I. Total increase in cash flow from operating activities (001 to 006) | 007 | 195.671.336 | 268.433.284 | ||
| 1. Decrease in short term liabilities | 008 | 72.670.143 | |||
| 2. Increase in short term receivables | 009 | 42.090.328 | |||
| 3. Increase in inventories | 010 | ||||
| 4. Other decrease in cash flow | 011 | 44.315.226 | 30.620.370 | ||
| II. Total decrease in cash flow from operating activities (008 to 011) | 012 | 86.405.554 | 103.290.513 | ||
| A1) NET INCREASE IN CASH FLOW FROM OPERATING ACTIVITIES (007-012) | 013 | 109.265.782 | 165.142.770 | ||
| A2) NET DECREASE IN IN CASH FLOW FROM OPERATING ACTIVITIES (012-007) | 014 | ||||
| CASH FLOW FROM INVESTING ACTIVITIES | |||||
| 1. Cash inflows from sales of long-term tangible and intangible assets | 015 | 765.000 | 111.000 | ||
| 2. Cash inflows from sales of equity and debt instruments | 016 | 57.008.000 | 16.502.228 | ||
| 3. Interests receipts | 017 | 3.492.000 | 2.163.000 | ||
| 4. Dividend receipts | 018 | ||||
| 5. Other cash inflows from investing activities | 019 | 1.616.000 | 359.400 | ||
| III. Total cash inflows from investing activities (015 to 019) | 020 | 62.881.000 | 19.135.628 | ||
| 1. Cash outflow for purchase of long-term tangible and intangible assets | 021 | 47.069.000 | 34.891.000 | ||
| 2. Cash outflow for acquisition of equity and debt financial instruments | 022 | 58.508.000 | 41.405.454 | ||
| 3. Other cash outflow for investing activities | 023 | 53.100 | 60.400 | ||
| IV. Total cash outflow for investing activities (021 do 023) | 024 | 105.630.100 | 76.356.854 | ||
| B1) NET INCREASE IN CASH FLOW FROM INVESTING ACTIVITIES (020-024) | 025 | ||||
| B2) NET DECREASE IN CASH FLOW FROM INVESTING ACTIVITIES (024-020) | 026 | 42.749.100 | 57.221.226 | ||
| CASH FLOW FROM FINANCIAL ACTIVITIES | |||||
| 1. Cash inflow from issuing property and debt financial instruments | 027 | $\Omega$ | |||
| 2. Proceeds from the credit principal, promissory notes, borrowings and other loans | 028 | 86.466.000 | 127.492.051 | ||
| 3. Other proceeds from financial activities | 029 | ||||
| V. Total cash inflows from financial activities (027 to 029) | 030 | 86.466.000 | 127.492.051 | ||
| 1. Cash outflow for repayment of credit principal and bonds | 031 | 177.062.000 | 173.002.010 | ||
| 2. Cash outflow for dividends paid | 032 | ΩI | 01 | ||
| 3. Cash outflow for financial lease | 033 | 1.789.000 | 2.875.000 | ||
| 4. Cash outflow for purchase of treasury shares | 034 | 01 | |||
| 5. Other cash outflow for financial activities | 035 | 0 | |||
| VI. Total cash outflow for financial activities (031 to 035) | 036 | 178.851.000 | 175.877.010 | ||
| C1) NET INCREASE IN CASH FLOW FROM FINANCIAL ACTIVITIES (030-036) | 037 | $\overline{0}$ | |||
| C2) NET DECREASE IN CASH FLOW FROM FINANCIAL ACTIVITIES (036-030) | 038 | 92.385.000 | 48.384.959 | ||
| Total increase in cash flow (013 - 014 + 025 - 026 + 037 - 038) | 039 | 59.536.585 | |||
| Total decrease in cash flow $(014 - 013 + 026 - 025 + 038 - 037)$ | 040 | 25.868.318 | $\overline{0}$ | ||
| Cash and cash equivalents at the beginning of the period | 041 | 145.959.842 | 118.207.528 | ||
| Increase of cash and cash equivalents | 042 | 59.536.585 | |||
| Decrease of cash and cash equivalents | 043 | 25.868.318 | $\overline{0}$ | ||
| Cash and cash equivalents at the end of the period | 044 | 120.091.524 | 177.744.113 |
STATEMENT OF CHANGES IN EQUITY for the period 1.1.2013. to 30.6.2013.
| Obligator: Podravka prehrambena industrija d.d., Koprivnica | ||||
|---|---|---|---|---|
| Item | Last year | Current year | ||
| $\mathbf{1}$ | 2 | $\overline{3}$ | $\overline{4}$ | |
| 1. Subscribed capital | 001 | 1.626.000.900 | 1.626.000.900 | |
| 2. Capital reserves | 002 | 26.465.000 | 26,465,000 | |
| 3. Reserves from profit | 003 | 105.899.405 | 99.852.633 | |
| 4. Retained earnings or accumulated loss | 004 | $-148.498.899$ | $-166.651.100$ | |
| 5. Profit or loss for the current year | 005 | $-14.101.876$ | 38.895.792 | |
| 6. Revaluation of long - term tangible assets | 006 | |||
| 7. Revaluation of intangible assets | 007 | |||
| 8. Revaluation of financial assets available for sale | 008 | |||
| 9. Other revaluation | 009 | 32.026.882 | 32.267.311 | |
| 10. Total capital and reserves (AOP 001 do 009) | 010 | 1.627.791.411 | 1.656.830.536 | |
| 11. Currency gains and losses arising from net investement in foreign operations | 011 | 13.639.170 | $-10.327.890$ | |
| 12. Current and deferred taxes (part) | 012 | |||
| 13. Cash flow hedging | 013 | |||
| 14. Changes in accounting policy | 014 | |||
| 15. Correction of significant errors in prior period | 015 | |||
| 16. Other changes of capital | 016 | $-14.995.139$ | 39.367.014 | |
| 17. Total increase or decrease in capital (AOP 011 do 016) | 017 | $-1.355.969$ | 29.039.124 | |
| 17 a. Attributed to equity holders of parent company | 018 | 1.404.513 | 28.798.695 | |
| 17 b. Attributed to minority interest | 019 | $-2.760.482$ | 240.429 |
Notes:
-
- The corrected net profit for first six months of 2013 is HRK 80.1 million, which is an increase of 72% compared to the net profit of the first six months of the year 2012, presented in a comparable manner.
-
- All levels of corrected profitability of the Podravka Group have recorded growth in the observed period, and non-recurrent items for which reported result is corrected amounted HRK 41.2 million and are entirely related to severance payments. Namely, the restructuring process has continued in the first six months of 2013 and the redundancy programme was thus conducted accordingly with the payment of incentive severance payments.
-
- The total costs and expenses of the Podravka Group are 1% lower compared to the same period of the year 2012 and if the total expenses were to be corrected for the amount of severance payments, the drop would be 3% compared to the total costs and expenses of the same period of 2012, presented in a comparable manner.
- The gross profit of the Podravka Group is 5% higher and amounts to HRK 691.3 million and the gross $\overline{4}$ . margin in the observed period is at the level of 40.8% and has recorded an increase of 250bp, respectively.
-
- The corrected operating profit is HRK 107.4 million, which is a growth of 18% compared to the operating profit of the same period of the year before, presented in a comparable manner, while the EBIT margin is 6.3% and is higher by 100bp than for the same period last year.
-
- The total sales of the Podravka Group in the first six months of the year 2013 were HRK 1,695.2 million, which represents a sales drop of 1% compared to the same period of the year 2012. Sales of the Strategic Business Area (SBA) Food and Beverages amounted to HRK 1,293.0 million and were 3% lower than in the same period of the year before while sales of the SBA Pharmaceuticals were HRK 402.2 million, which is a 4% increase of sales.
-
- The General Assembly of Belupo d.d passed the resolution to increase its share capital from the realised profit, thus the share capital has increased by the HRK 50,000,000.00 and is now HRK 204,025,800.00.
-
- At the General Assembly of Podravka d.d., held on 20 June 2013, draft resolutions of both the Management Board and the Supervisory Board were accepted. The main changes refer to the Articles of Associations, are:
- the Government is no longer able to directly nominate two members of the Supervisory Board.
- possible increase of the company capital in a manner that the Management Board, with an approval by the Supervisory Board, would be able to pass a resolution on Company recapitalization, to the amount of half of the share capital.
- reducing the company share capital in the amount of HRK 542 million in order to cover from previous periods. accumulated losses The reduction of company share capital shall be performed by reducing the nominal amount of regular shares from HRK 300.00 to HRK 200.00 per share. This also creates presuppositions for shareholders to make future decisions on the distribution of profit (dividend payment, retaining profit, increase of share capital and similar).
Podravka continues with the already started restructuring process and has announced the divesting of the business programmes Beverages, Bakery and a part of the Frozen programme, accordingly.
- Podravka products have received eight international awards for top quality and taste at the Superior Taste Award 2013 in Brussels confirming once more that the quality of Podravka brands is well recognised on international markets. Podravka tomato purée - passata and Podravka chopped tomato with basil and oregano received two stars as well, and the sign Superior Taste Award this year also belongs to Podravka chopped tomato with olives and garlic, Piquant sausage and Chicken pâté, as they received one star each. Studenac received the maximum three stars just like last year and the excellence of Studenac orange-kumquat and Studenac lemon-grape was awarded with two stars.
COMPANY MANAGEMENT
Koprivnica, 18th July 2013
MANAGEMENT REPORT ON THE ACHIEVED BUSINESS RESULTS OF THE PODRAVKA GROUP FOR THE PERIOD JANUARY - JULY 2013
Main business characteristics and significant events in the first six months of the year 2013
-
- The corrected net profit for first six months of 2013 is HRK 80.1 million, which is an increase of 72% compared to the net profit of the first six months of the year 2012, presented in a comparable manner.
-
- All levels of corrected profitability of the Podravka Group have recorded growth in the observed period, and non-recurrent items for which reported result is corrected amounted HRK 41.2 million and are entirely related to severance payments. Namely, the restructuring process has continued in the first six months of 2013 and the redundancy programme was thus conducted accordingly with the payment of incentive severance payments.
-
- The total costs and expenses of the Podravka Group are 1% lower compared to the same period of the year 2012 and if the total expenses were to be corrected for the amount of severance payments, the drop would be 3% compared to the total costs and expenses of the same period of 2012, presented in a comparable manner.
-
- The gross profit of the Podravka Group is 5% higher and amounts to HRK 691.3 million and the gross margin in the observed period is at the level of 40.8% and has recorded an increase of 250bp, respectively.
-
- The corrected operating profit is HRK 107.4 million, which is a growth of 18% compared to the operating profit of the same period of the year before, presented in a comparable manner, while the EBIT margin is 6.3% and is higher by 100bp than for the same period last year.
-
- The total sales of the Podravka Group in the first six months of the year 2013 were HRK 1,695.2 million, which represents a sales drop of 1% compared to the same period of the year 2012. Sales of the Strategic Business Area (SBA) Food and Beverages amounted to HRK 1,293.0 million and were 3% lower than in the same period of the year before while sales of the SBA Pharmaceuticals were HRK 402.2 million, which is a 4% increase of sales.
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no. MBS 010006549, PIN 18928523252 Privredna banka Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,626,000,900.00 HRK paid in full, number of shares: 5,420,003, nominal share value: 300.00 HRK, President of the Supervisory Board: D. Stimac, President of the Management Board: Z. Mršić, Board members: J. Ivanković, O. Jakupec, M. Klepač, H Kolarić, J. Pedersen
-
- The General Assembly of Belupo d.d passed the resolution to increase its share capital from the realised profit, thus the share capital has increased by the HRK 50,000,000.00 and is now HRK 204,025,800.00.
-
- At the General Assembly of Podravka d.d., held on 20 June 2013, draft resolutions of both the Management Board and the Supervisory Board were accepted. The main changes refer to the Articles of Associations, are:
- the Government is no longer able to directly nominate two members of the Supervisory Board,
- possible increase of the company capital in a manner that the Management Board, with an approval by the Supervisory Board, would be able to pass a resolution on Company recapitalization, to the amount of half of the share capital.
- reducing the company share capital in the amount of HRK 542 million in order from previous periods. accumulated losses to cover The reduction of company share capital shall be performed by reducing the nominal amount of regular shares from HRK 300.00 to HRK 200.00 per share. This also creates presuppositions for shareholders to make future decisions on the distribution of profit (dividend payment, retaining profit, increase of share capital and similar).
Podravka continues with the already started restructuring process and has announced the divesting of the business programmes Beverages, Bakery and a part of the Frozen programme, accordingly.
- Podravka products have received eight international awards for top quality and taste at the Superior Taste Award 2013 in Brussels confirming once more that the quality of Podravka brands is well recognised on international markets. Podravka tomato purée - passata and Podravka chopped tomato with basil and oregano received two stars as well, and the sign Superior Taste Award this year also belongs to Podravka chopped tomato with olives and garlic, Piquant sausage and Chicken pâté, as they received one star each. Studenac received the maximum three stars just like last year and the excellence of Studenac orange-kumquat and Studenac lemon-grape was awarded with two stars.
Expected future development
-
- The goal of the Podravka Group is to be the leading food company on strategic markets and a recognizable provider of pharmaceutical products.
- The Podravka Group wishes to reach a level of efficiency that is above the $2.$ average of industries in countries in which it operates thus realizing the interests of its owners, to enable cash flow improvements by better financial management which is essential for optimal business operations and company stability and to enable greater investments in marketing, research and development by reducing the costs of purchasing, sales, distribution, general and administrative expenses.
- The highest contribution to the increase of revenue in Croatia, South-East and $31$ Central Europe is expected from the further development of current products and the launching of new products within the most significant and most profitable categories. The Podravka Group shall continue its anorganic growth with acquisitions and strategic alliances on the markets of South-East, Central and Eastern Europe.
Research and Development activities
The basic activities of Research and Development are focused on the development of new products and the advancement of current products by following the developments of food science and consumer trends and the products are continuously tailored to meet the present public awareness of a proper and healthy diet. Special attention is given to the organoleptic quality and nutrient features as well as the design and quality of information on product declarations.
Research and development is constantly working on the improvement of production and controlling processes. The use of modern technology and the Central semi-industrial lab, unique in this region, create new opportunities that are essential for company progress and growth.
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no. MBS 010006549, PIN 18928523252 Privredna banks Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,626,000,900.00 HRK paid in full,
Privredna banks Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1, Management Board: Z. Mršić, Board members: J. Ivanković, O. Jakupec, M. Klepač, H Kolarić, J. Pedersen
Information on the redemption of own shares
There was no redemption of own shares in the previous period nor is there any intention of own share redemption.
Related companies
The Podravka Group consists of the parent company Podravka d.d. and 24 subsidiary companies of which 8 companies are located in Croatia and 16 abroad;
Financial risk management and company exposure to price, credit, liquidity and cash flow risks
As the Group is exposed to price changes of raw material for the food industry, world trends on the commodity exchange are carefully monitored and "market" reports" of strategic suppliers are used as the grounds to react on a spot market at the moment when prices of raw material are most favourable.
Credit risk and the risk of outstanding payments or non-fulfilment of contractual liabilities from customers have impact on the Group's contingent financial loss which is the reason why the Group has adopted the "Credit Risk Management Procedure" that it applies in dealing with customers. The Group collects payment insurance instruments whenever possible in order to protect itself from contingent financial risk and loss due to non-fulfilled payments or contractual liabilities.
The Group is largely financed by loans in foreign currency and therefore exposed to the risk of exchange rate differences. The Group uses loans with fixed and variable interest rates where the majority of loans has been agreed with variable interest rates and is therefore exposed to the risk of interest rate changes.
The Management establishes an adequate frame of liquidity risk management in order to manage short-term, medium-term and long-term financial and liquidity requirements. The Group manages liquidity risk by maintaining adequate reserves and credit lines, continuously comparing the planned and realized cash flow and monitoring due receivables and current liabilities.
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no. MBS 010006549, PIN 18928523252 Privredna banka Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,626,000,900.00 HRK paid in full,
number of shares: 5,420,003, nominal share value: 300.00 HRK, President of the Superviso Management Board: Z. Mršić, Board members: J. Ivanković, O. Jakupec, M. Klepač, H Kolarić, J. Pedersen
Comments on the reported period
Sales revenue of the Podravka Group in the first six months of the year 2013 amounted to HRK 1,695.2 million, which is 1% less compared to the same period of the year 2012.
Sales of the SBA Food and Beverages totalled HRK 1,293.0 million, which represents sales drop of 3% compared to the first six months of 2012. The sales drop primarily results from a lower level of sales of the SBA F&B on the domestic market and a somewhat lower level of sales achieved on the market of South-Eastern Europe. At the same time, the markets of Central Europe, South-Eastern Europe and Western Europe, overseas countries and Orient grew, with the highest contribution coming from Poland, Hungary, Kosovo, Serbia and Austria.
The SBA Pharmaceuticals achieved sales in the amount of HRK 402.2 million, which represents an increase of 4% compared to the same period of 2012. Foreign markets mostly contributed to the sales growth of the SBA Pharmaceuticals, with a 7% growth and the highest contribution coming from the markets of Russia, Kosovo and Serbia. Sales on the Croatian market are also on a somewhat higher level than in the same period of 2012, based on increased sales of prescription drugs and if the sales structure in Croatia is observed according to the ATC classification, the product groups with the most significant growth are drugs that affect heart and blood vessels and the nervous system.
Sales in the amount of HRK 736.4 million, which is 43.4% of the total sales of the Podravka Group, was realised on the market of Croatia and is 5% lower compared with the same period of last year. Total sales on foreign markets are HRK 958.8 million and are 2% higher than in the first year-half of 2012, and all foreign market groups have recorded growth in the observed period. Market of South-Eastern Europe realised sales growth of 1% with the most prominent markets being Kosovo and Serbia, while sales in Bosnia and Herzegovina recorded a drop due to unfavourable macroeconomic movements. The highest growth of total sales on the market of Central Europe was recorded in Poland and Hungary, while on the market of Western Europe, overseas markets and Orient the highest contribution comes from Austria, Great Britain and Scandinavia. In Eastern Europe sales growth results from Russia based on the sales growth of the SBA Pharmaceuticals.
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no, MBS 010006549, PIN 18928523252 Privredna banka Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,626,000,900.00 HRK paid in full, number of shares: 5,420,003, nominal share value: 300.00 HRK, President of the Supervisory Board: D. Štimac, President of the Management Board: Z. Mršić, Board members: J. Ivanković, O. Jakupec, M. Klepač, H Kolarić, J. Pedersen
COMPANY MANAGEMENT
Other operating income realised in period 1.-6.2013 is HRK 33.3 million and are 39% lower compared to period 1.-6.2012.
The total operating costs and expenses is achieved in the amount of HRK 1,654.6 million and is 2% lower than those achieved in the same period last year.
The majority of operating costs and expenses refers to material costs (64%) and employee costs also hold a significant share in the structure of operating costs and expenses (20%).
Financial expenses realized in the period 1.-6.2013. is HRK 53.4 million and are 11% lower than those realized in the same period of the year before.
The realised operating profit is HRK 66.2 million, while the net profit of the period 1.-6.2013. is HRK 38.9 million.
The total value of assets of the Podravka Group as of 30 June 2013 is HRK 3,514.2 million and compared to the year end of 2012 is HRK 103.4 million less. The highest contribution on decrease of assets is coming from lower trade and other receivables, which have decreased for HRK 122.3 million. Inventories also recorded a drop, and compared to the end of 2012 are lower for HRK 18.7 million. Regarding liabilities, trade and other payables recorded a significant decrease in amount of HRK 75.5 million.
The indebtedness of the Podravka Group as of 30 June 2013 is HRK 1,134.1 million and compared to the year end of 2012 has been decrease by HRK 63.8 million. The net debt as of 30 June 2013 is HRK 956.4 million which is a decrease of HRK 123.3 million compared to the year 2012.
President of the Management Board:
Zvonimir Mršić
AQUANUM
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no. MBS 010006549, PIN 18928523252 Privredna banka Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,626,000,900.00 HRK paid in full,
number of shares: 5,420,003, nominal share value: 300.00 HRK, President of the Superviso Management Board: Z. Mršić, Board members: J. Ivanković, O. Jakupec, M. Klepač, H Kolarić, J. Pedersen
COMPANY MANAGEMENT
Koprivnica, 18th July 2013
STATEMENT FROM EXECUTIVES RESPONSIBLE FOR PREPARING FINANCIAL STATEMENTS
Consolidated financial statements of the Podravka Group for the period January - June 2013 have been prepared in compliance with the Accounting Act of the Republic of Croatia and International Financial Reporting Standards (IFRS) and provide an overall and true presentation of assets, liabilities, profit and loss, financial position and business operations of the Group and all related companies involved in the consolidation.
During the observed period, there were no changes in accounting policies of the Podravka Group.
Finance Director: Draga Celiščak
Clincol X
Board Member: Miroslav Klebač
PODRAVKA d.d., Koprivnica, Ante Starčevića 32, Commercial Court of Varaždin, Company no. MBS 010006549, PIN 18928523252 Privredna banka Zagreb d.d., Zagreb, Račkoga 6, Giro account no. 2340009-1100098526, share capital 1,626,000,000.00 HRK paid in full,
number of shares: 5,420,003, nominal share value: 300.00 HRK, President of the Superviso